LABIXIAOXIN (01262) has announced that it expects the group to achieve total sales of approximately RMB 970 million for the fiscal year ending December 31, 2025. This represents an increase compared to the total sales of approximately RMB 867 million for the year ended December 31, 2024. The company anticipates an after-tax profit of about RMB 11.7 million for the 2025 fiscal year, contrasting with an after-tax loss of RMB 93.5 million reported for the 2024 fiscal year.

The growth in total sales for the 2025 fiscal year is primarily attributed to increased sales through snack chain convenience stores and e-commerce channels. The improvement from a loss to an after-tax profit is mainly due to several factors: higher sales volume generated via snack chain convenience stores and e-commerce platforms; a decrease in expected credit loss provisions for trade receivables; and a combined effect of reduced advertising, promotion expenses, and administrative expenses resulting from cost-control measures implemented by the group during the 2025 fiscal year.